GBCMY Statistics
Total Valuation
Global Bio-chem Technology Group Company has a market cap or net worth of 117.78 million. The enterprise value is 822.81 million.
| Market Cap | 117.78M |
| Enterprise Value | 822.81M |
Important Dates
The next estimated earnings date is Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +58.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.24B |
Valuation Ratios
The trailing PE ratio is 0.22.
| PE Ratio | 0.22 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.55 |
| EV / Sales | 3.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 93.48 |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 56.37 |
| Interest Coverage | -0.77 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -4.90% |
| Return on Capital (ROIC) | -19.66% |
| Revenue Per Employee | 88,844 |
| Profits Per Employee | 203,520 |
| Employee Count | 2,154 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 5.96 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.24% in the last 52 weeks. The beta is 0.84, so Global Bio-chem Technology Group Company's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -49.24% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 33.35 |
| Average Volume (20 Days) | 258 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Global Bio-chem Technology Group Company had revenue of 231.00 million and earned 529.15 million in profits. Earnings per share was 0.04.
| Revenue | 231.00M |
| Gross Profit | 21.31M |
| Operating Income | -52.58M |
| Pretax Income | 461.51M |
| Net Income | 529.15M |
| EBITDA | -19.45M |
| EBIT | -52.58M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 16.07 million in cash and 496.16 million in debt, giving a net cash position of -480.09 million.
| Cash & Cash Equivalents | 16.07M |
| Total Debt | 496.16M |
| Net Cash | -480.09M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -345.44M |
| Book Value Per Share | -0.06 |
| Working Capital | -748.15M |
Cash Flow
In the last 12 months, operating cash flow was 14.28 million and capital expenditures -5.47 million, giving a free cash flow of 8.80 million.
| Operating Cash Flow | 14.28M |
| Capital Expenditures | -5.47M |
| Free Cash Flow | 8.80M |
| FCF Per Share | n/a |
Margins
Gross margin is 9.22%, with operating and profit margins of -22.76% and 229.07%.
| Gross Margin | 9.22% |
| Operating Margin | -22.76% |
| Pretax Margin | 199.79% |
| Profit Margin | 229.07% |
| EBITDA Margin | -8.42% |
| EBIT Margin | -22.76% |
| FCF Margin | 3.81% |
Dividends & Yields
Global Bio-chem Technology Group Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.07% |
| Shareholder Yield | -58.07% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Global Bio-chem Technology Group Company has an Altman Z-Score of -4.14. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.14 |
| Piotroski F-Score | n/a |